Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-09-27 17:11:34 - browse：66977

Earlier this month, Intellia Therapeutics announced it was scrapping plans to include U.S.-based sites in one of its mid-stage CRISPR trials after the Food and Drug Administration requested additional data to support including female patients of childbearing potential. The move left many researchers wondering whether the specter of accidental germline transmission — which haunted early gene therapy trials — had now risen over the field of gene editing.

Over the weekend, Intellia sought to assure the gene editing community that no such thing is happening. At a meeting at Cold Spring Harbor Laboratory that drew more than 400 of the field’s top scientists, the company shared more detailed information about studies it has conducted to assess the risks that renegade CRISPR components could be getting into an egg or sperm. These studies demonstrate “that there’s no evidence of vertical germline transmission of those edits,” Jonathan Phillips, head of pharmacology and toxicology at Intellia, said during a presentation Saturday.

Intellia is one of the leading companies working to advance in vivo gene editing therapies. In a landmark study published in the New England Journal of Medicine in 2021, Intellia revealed data from six patients in its trial for a transthyretin amyloidosis therapy — showing for the first time that it was possible to precisely alter the DNA of particular cells within the human body to treat disease with a one-time infusion of CRISPR. Included in the supplementary material was a redacted version of the company’s package requesting authorization to start its clinical trial. It noted that during toxicology studies in non-human primates, Intellia scientists discovered that editing had taken place at low levels in organs other than the liver, including the spleen and adrenal glands. In three out of 12 female monkeys, they also found editing in the animals’ ovaries.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： The strategy behind pharma's lawsuits over drug pricing reform

hotspot

WSS

With FDA staff opposed to Sarepta therapy, top official intervened

New guidelines on severe brain injury complicate already difficult decisions

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

Death of patient in Alzheimer’s trial raises question of possible risks

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

American Airlines has a tentative contract deal with its pilots. Southwest is still negotiating

focus

Wikipedia

focus

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Biden announces an advanced cancer research initiative

Malaria cases in Florida and Texas: Here’s what you need to know

WATCH: Why do fingernails fall off when they're damaged?

Dobbs anniversary: the lost opportunity of abortion as health care

Stoke drug shows lower activity against childhood epilepsy

Trump demands the U.S. pay no more for drugs than other countries … again

McConnell had minor fall 2 weeks ago, uses wheelchair periodically to get around: Sources

Hepatitis C has a cure — but many Americans still lack access to it

CDC: Cases of alpha

hotspot

Bryan Kohberger seeks indictment dismissal in Idaho college killings case

Trader Joe's recalls 10K cases of broccoli cheddar soup over potential foreign material

Biden announces an advanced cancer research initiative

Ending health disparities requires full federal government, panel says

The battle over the Brookhaven Landfill on Long Island

Trump allegedly attempted to have surveillance video deleted: Special Counsel

focus

hotspot

Wikipedia

focus